Client News

Abivax treats first patient in Phase 2b/3 ABX464 Covid-19 clinical trial

PAION announces U.S. FDA Approval of remimazolam (BYFAVOTM) for the induction and maintenance of procedural sedation

Publication in PNAS unveils molecular pathway required for influenza virus replication with large potential as an antiviral drug target

MagForce AG Publishes Financial Results for the Year 2019 and Operative Highlights

CENTOGENE AG: CENTOGENE, Lufthansa, and Fraport Launch the First Walk-In COVID-19 Testing Facility in Germany at Frankfurt Airport

Heidelberg Pharma to Present at the Upcoming Virtual European Biotech Investor Day 2020

CENTOGENE AG: Einladung zur Eröffnung des ersten Flughafen-Corona-Test (FCT) Zentrums in Deutschland

Royalty Pharma Acquires Partial Royalty Interest on Prevymis™ (Letermovir) from AiCuris Anti-infective Cures GmbH

Abivax provides business update on most recent achievements and announces positive results of annual ordinary and extraordinary general meeting

AFFiRiS AG: The Lancet Neurology publishes positive results of AFFiRiS’ Phase 1 trial with PD01A in Parkinson’s disease patients